Comment from Syneos Health
AnonymousSupportBusiness
Summary: Syneos Health, a Contract Research Organization (CRO), expresses strong support for the AI-enabled clinical trials pilot program. They provide detailed recommendations on prioritizing oncology and rare disease trials, specific AI use cases like real-time safety monitoring, and methodologies for rigorous comparative evaluation.
Syneos Health would like to take this opportunity to respond to the RFI request, regarding AI enabled technology to support Real Time Clinical Trials. As a CRO supporting many development programs we are eager to be an active participate in the next steps, in the future of drug development. Please see our attachment.